Abstract
Convalescent plasma therapy has been used for years. However, its use in Covid-19 is still experimental. While it can be life-saving, its efficacy as well as risks need to be evaluated to establish this as a therapeutic option. Also, for this proper infrastructure and adequate facilities need to be in place before embarking on this journey. However, under current circumstances, convalescent plasma should be strictly only given in the setting of clinical trials.
Cite
CITATION STYLE
Mahmood, A., Mahmood, R., Khan, M., Ali, S., Khan, N., & Jaffar, S. R. (2021). Convalescent plasma therapy for Covid 19 - A perspective. Hematology & Transfusion International Journal, 9(2), 28–30. https://doi.org/10.15406/htij.2021.09.00247
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.